Revolution Medicines shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Revolution Medicines
Tip: Access up to 7 years of quarterly data
All positions including Revolution Medicines held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revolution Medicines by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.8M | 133k | 28.68 |
| 2023-09-30 | $2.9M | 104k | 27.68 |
| 2023-06-30 | $2.0M | 90k | 21.66 |
| 2023-03-31 | $2.0M | 90k | 21.66 |
| 2022-12-31 | $1.5M | 63k | 23.82 |
| 2022-09-30 | $868k | 44k | 19.72 |
| 2022-06-30 | $848k | 44k | 19.49 |
| 2022-03-31 | $1.5M | 58k | 25.51 |
| 2021-12-31 | $1.0M | 41k | 25.17 |
| 2021-09-30 | $1.1M | 39k | 27.51 |
| 2021-06-30 | $1.2M | 39k | 31.74 |
| 2021-03-31 | $1.0M | 22k | 45.88 |
| 2020-12-31 | $983k | 25k | 39.59 |
| 2020-09-30 | $247k | 7.1k | 34.80 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas